VIVUS (STU:VIU1) COGS-to-Revenue : 0.24 (As of Mar. 2020)

View and export this data going back to . Start your Free Trial

What is VIVUS COGS-to-Revenue?

VIVUS's Cost of Goods Sold for the three months ended in Mar. 2020 was €4.19 Mil. Its Revenue for the three months ended in Mar. 2020 was €17.77 Mil.

VIVUS's COGS to Revenue for the three months ended in Mar. 2020 was 0.24.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. VIVUS's Gross Margin % for the three months ended in Mar. 2020 was 76.43%.

VIVUS COGS-to-Revenue Historical Data

The historical data trend for VIVUS's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIVUS COGS-to-Revenue Chart

VIVUS Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

COGS-to-Revenue

Get a 7-Day Free Trial

0.36

0.08

0.25

0.22

VIVUS Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
COGS-to-Revenue	Get a 7-Day Free Trial															0.27	0.24	0.17	0.23	0.24

VIVUS COGS-to-Revenue Calculation

VIVUS's COGS to Revenue for the fiscal year that ended in Dec. 2019 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	14.104	/	62.784
	=	0.22

VIVUS's COGS to Revenue for the quarter that ended in Mar. 2020 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4.187	/	17.766
	=	0.24

VIVUS (STU:VIU1) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

VIVUS's Gross Margin % for the three months ended in Mar. 2020 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4.187 / 17.766
	=	76.43 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

VIVUS COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of VIVUS's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

VIVUS (STU:VIU1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VIVUS Inc (STU:VIU1) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 East Hamilton Avenue, Suite 550, Campbell, CA, USA, 95008

Website

http://www.vivus.com

VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic enzyme preparation consisting of pancrelipase, an extract derived from porcine pancreatic glands, as well as other enzyme classes and STENDRA/SPEDRA, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction.

VIVUS (STU:VIU1) Headlines

No Headlines